Human Genome Epidemiology Literature Finder
Records 1 - 30 (of 77 Records) |
Query Trace: Lung Neoplasms and KEAP1[original query] |
---|
Genomic Profiling Reveals Novel Predictive Biomarkers for Chemo-Radiotherapy Efficacy and Thoracic Toxicity in Non-Small-Cell Lung Cancer. Frontiers in oncology 2022 12 928605. He Kewen, Zhang Shaotong, Pang Jiaohui, Yin Jiani C, Mu Dianbin, Wang Jun, Ge Hong, Ma Jie, Yang Zhe, Zheng Xiaoli, Dong Lihua, Zhang Junli, Chang Pengyu, Li Li, Tang Shanshan, Bao Hua, Wu Xue, Wang Xiaonan, Shao Yang, Yu Jinming, Yuan Shuang |
Clinical outcomes and immune phenotypes associated with STK11 co-occurring mutations in non-small cell lung cancer. Journal of thoracic disease 2022 7 14 (6): 1772-1783. Malhotra Jyoti, Ryan Brid, Patel Malini, Chan Nancy, Guo Yanxiang, Aisner Joseph, Jabbour Salma K, Pine Shar |
STK11 and KEAP1 mutations in non-small cell lung cancer patients: Descriptive analysis and prognostic value among Hispanics (STRIKE registry-CLICaP). Lung cancer (Amsterdam, Netherlands) 2022 Jun 170 114-121. Cordeiro de Lima Vladmir C, Corassa Marcelo, Saldanha Erick, Freitas Helano, Arrieta Oscar, Raez Luis, Samtani Suraj, Ramos Maritza, Rojas Carlos, Burotto Mauricio, Chamorro Diego F, Recondo Gonzalo, Ruiz-Patiño Alejandro, Más Luis, Zatarain-Barrón Lucia, Mejía Sergio, Nicolas Minata José, Martín Claudio, Bautista Blaquier Juan, Motta Guerrero Rodrigo, Aliaga-Macha Carlos, Carracedo Carlos, Ordóñez-Reyes Camila, Garcia-Robledo Juan Esteban, Corrales Luis, Sotelo Carolina, Ricaurte Luisa, Santoyo Nicolas, Cuello Mauricio, Jaller Elvira, Rodríguez July, Archila Pilar, Bermudez Maritza, Gamez Tatiana, Russo Alessandro, Viola Lucia, Malapelle Umberto, de Miguel Perez Diego, Rolfo Christian, Rosell Rafael, Cardona Andrés |
Survival Outcomes and Treatment Patterns in Patients With NFE2L2 and/or KEAP1 Mutation-Positive Advanced Squamous Cell NSCLC Using a Real-World Clinico-Genomic Database. Clinical lung cancer 2022 6 23 (6): 487-497. Wu Yanyu, Yin Yu, Crossland Victoria, Vincent Sylvie, Paik Paul K, Lineberry Neil, Faller Douglas |
Clinicopathologic and Genomic Landscape of Non-Small Cell Lung Cancer Brain Metastases. The oncologist 2022 May . Huang Richard S P, Harries Lukas, Decker Brennan, Hiemenz Matthew C, Murugesan Karthikeyan, Creeden James, Tolba Khaled, Stabile Laura P, Ramkissoon Shakti H, Burns Timothy F, Ross Jeffrey |
The prevalence and real-world therapeutic analysis of Chinese patients with KRAS-Mutant Non-Small Cell lung cancer. Cancer medicine 2022 4 11 (19): 3581-3592. Chen Hanxiao, Huang Dingzhi, Lin Gen, Yang Xue, Zhuo Minglei, Chi Yujia, Zhai Xiaoyu, Jia Bo, Wang Jingjing, Wang Yuyan, Li Jianjie, An Tongtong, Wu Meina, Wang Ziping, Zhao J |
Genomic and clinicopathological features of lung adenocarcinomas with micropapillary component. Frontiers in oncology 2022 12 12 989349. Li Peng, Liu Lu, Wang Dong, Yang Ronghua, Xuan Yunpeng, Han Yudong, Wang Jinglong, Guo Lijie, Zhang Liwen, Zhang Shanshan, Wang Yongj |
Targeting NFE2L2/KEAP1 Mutations in Advanced NSCLC With the TORC1/2 Inhibitor TAK-228. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2022 10 . Paik Paul K, Fan Pang-Dian, Qeriqi Besnik, Namakydoust Azadeh, Daly Bobby, Ahn Linda, Kim Rachel, Plodkowski Andrew, Ni Ai, Chang Jason, Fanaroff Rachel, Ladanyi Marc, de Stanchina Elisa, Rudin Charles |
Differential prognostic effect of systemic inflammation in patients with non-small cell lung cancer treated with immunotherapy or chemotherapy: A post hoc analysis of the phase 3 OAK trial. Cancer 2022 Jun . Cortellini Alessio, Ricciuti Biagio, Borghaei Hossein, Naqash Abdul Rafeh, D'Alessio Antonio, Fulgenzi Claudia A M, Addeo Alfredo, Banna Giuseppe L, Pinato David Jam |
Probing Mutant KRAS, STK11, KEAP1 in NSCLC. Cancer discovery 2022 Aug OF1. Authors are not available |
Coexisting Genomic Alterations in Risk Stratification of KRASG12C-Mutated Non-Small Cell Lung Cancer. Cancer discovery 2023 7 13 (7): 1513-1515. Sarina Z W Heng, Regina Hoo, Daniel S W T |
Overall survival in patients with advanced non-small cell lung cancer with KRAS G12C mutation with or without STK11 and/or KEAP1 mutations in a real-world setting. BMC cancer 2023 4 23 (1): 352. Julian Cristina, Pal Navdeep, Gershon Anda, Evangelista Marie, Purkey Hans, Lambert Peter, Shi Zhen, Zhang Qi |
Concurrent Mutations in STK11 and KEAP1 Cause Treatment Resistance in KRAS Wild-type Non-small-cell Lung Cancer. Internal medicine (Tokyo, Japan) 2023 3 . Sumii Masahiko, Namba Masashi, Tokumo Kentaro, Yamauchi Masami, Okamoto Wataru, Hattori Noboru, Sugiyama Kazuhi |
Frequently mutated genes in predicting the relapse of stage I lung adenocarcinoma. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 2023 2 . Rao Wen, Yang Lujie, Dai Nan, Zhang Liang, Liu Jie, Yang Bo, Li Mengxia, Shan Jinlu, Wang Qiushi, Wang Do |
Analysis of Tumor Mutational Burden, Progression-Free Survival, and Local-Regional Control in Patents with Locally Advanced Non-Small Cell Lung Cancer Treated With Chemoradiation and Durvalumab. JAMA network open 2023 1 6 (1): e2249591. Lebow Emily S, Shepherd Annemarie, Eichholz Jordan E, Offin Michael, Gelblum Daphna Y, Wu Abraham J, Simone Charles B, Schoenfeld Adam J, Jones David R, Rimner Andreas, Chaft Jamie E, Riaz Nadeem, Gomez Daniel R, Shaverdian Nar |
Associations of tissue tumor mutational burden and mutational status with clinical outcomes in KEYNOTE-042: pembrolizumab versus chemotherapy for advanced PD-L1-positive NSCLC. Annals of oncology : official journal of the European Society for Medical Oncology 2023 1 . Mok T S K, Lopes G, Cho B C, Kowalski D M, Kasahara K, Wu Y-L, de Castro G, Turna H Z, Cristescu R, Aurora-Garg D, Loboda A, Lunceford J, Kobie J, Ayers M, Pietanza M C, Piperdi B, Herbst R |
Molecular profiling METex14+ non-small cell lung cancer (NSCLC): Impact of histology. Lung cancer (Amsterdam, Netherlands) 2024 9 196 107935. Jennifer A Marks, Nishant Gandhi, Balazs Halmos, Melina E Marmarelis, So Yeon Kim, Lyudmila Bazhenova, Suresh S Ramalingam, Joanne Xiu, Phillip Walker, Matthew J Oberley, Patrick C Ma, Stephen V L |
Specific cancer types and prognosis in patients with variations in the KEAP1-NRF2 system: A retrospective cohort study. Cancer science 2024 9 . Tomoyuki Iwasaki, Hidekazu Shirota, Keiju Sasaki, Kota Ouchi, Yuki Nakayama, Hiroyuki Oshikiri, Akihito Otsuki, Takafumi Suzuki, Masayuki Yamamoto, Chikashi Ishio |
Ancestry-, Sex-, and Age-Based Differences of Gene Alterations in NSCLC: From the Real-World Data of Cancer Genomic Profiling Tests. Journal of the National Comprehensive Cancer Network : JNCCN 2024 8 1-10. Keita Miura, Takehito Shukuya, Ray Greenstein, Ben Kaplan, Heather Wakelee, Kana Kurokawa, Kazuyuki Furuta, Shunsuke Kato, Junghee Suh, Smruthy Sivakumar, Ethan S Sokol, David P Carbone, Kazuhisa Takahas |
Lung-MAP Next Generation Sequencing Analysis of Advanced Squamous Cell Lung Cancers (SWOG S1400). Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2024 8 . David Kozono, Xing Hua, Michael C Wu, Khaled A Tolba, Saiama N Waqar, Konstantin H Dragnev, Haiying Cheng, Fred R Hirsch, Philip C Mack, Jhanelle E Gray, Karen Kelly, Hossein Borghaei, Roy S Herbst, David R Gandara, Mary W Redm |
TP53 co-mutations in advanced lung adenocarcinoma: comparative bioinformatic analyses suggest ambivalent character on overall survival alongside KRAS, STK11 and KEAP1 mutations. Frontiers in oncology 2024 8 14 1357583. Armin Frille, Myriam Boeschen, Hubert Wirtz, Mathias Stiller, Hendrik Bläker, Maximilian von Laffe |
Transcriptional phenocopies of deleterious KEAP1 mutations correlate with survival outcomes in lung cancer treated with immunotherapy. Clinical cancer research : an official journal of the American Association for Cancer Research 2024 7 . Stefano Scalera, Biagio Ricciuti, Daniele Marinelli, Marco Mazzotta, Laura Cipriani, Giulia Bon, Giulia Schiavoni, Irene Terrenato, Alessandro Di Federico, Joao V Alessi, Maurizio Fanciulli, Ludovica Ciuffreda, Francesca De Nicola, Frauke Goeman, Giulio Caravagna, Daniele Santini, Ruggero De Maria, Federico Cappuzzo, Gennaro Ciliberto, Mariam Jamal-Hanjani, Mark M Awad, Nicholas McGranahan, Marcello Maugeri-Sac |
SWI/SNF family mutations in advanced NSCLC: genetic characteristics and immune checkpoint inhibitors' therapeutic implication. ESMO open 2024 6 9 (6): 103472. L-L Pang, H-Q Zhou, Y-X Zhang, W-T Zhuang, F Pang, L-J Chen, J Liao, Y-H Huang, T-Q Mao, Z-H Mai, L Zhang, W-F Fa |
Decision model for durable clinical benefit from front- or late-line immunotherapy alone or with chemotherapy in non-small cell lung cancer. Med (New York, N.Y.) 2024 5 . Jie Zhao, Lu Wang, Anda Zhou, Shidi Wen, Wenfeng Fang, Li Zhang, Jianchun Duan, Hua Bai, Jia Zhong, Rui Wan, Boyang Sun, Wei Zhuang, Yiwen Lin, Danming He, Lina Cui, Zhijie Wang, Jie Wa |
Combining genomic biomarkers to guide immunotherapy in non-small cell lung cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 2024 2 . Joris van de Haar, Joanne M Mankor, Karlijn Hummelink, Kim Monkhorst, Egbert F Smit, Lodewyk F A Wessels, Edwin Cuppen, Joachim G J V Aerts, Emile E Voe |
Pan-cancer analysis of biallelic inactivation in tumor suppressor genes identifies KEAP1 zygosity as a predictive biomarker in lung cancer. Cell 2024 12 . Mark Zucker, Maria A Perry, Samuel I Gould, Arielle Elkrief, Anton Safonov, Rohit Thummalapalli, Miika Mehine, Debyani Chakravarty, A Rose Brannon, Marc Ladanyi, Pedram Razavi, Mark T A Donoghue, Yonina R Murciano-Goroff, Kristiana Grigoriadis, Nicholas McGranahan, Mariam Jamal-Hanjani, Charles Swanton, Yuan Chen, Ronglai Shen, Sarat Chandarlapaty, David B Solit, Nikolaus Schultz, Michael F Berger, Jason Chang, Adam J Schoenfeld, Francisco J Sánchez-Rivera, Ed Reznik, Chaitanya Bandlamu |
Genetic profile in primary tumor tissue of advanced lung adenocarcinoma patients with adrenal metastasis. Cancer genetics 2024 12 290-291 36-43. Haiqiao Pan, Hongbin Zhang, Yongqian Zhang, Xiaojing Chen, Zhai Liu, Yajing Wu, Na Bai, Yan Shi, Min Zhao, Lingling Z |
Effective treatment strategies and key factors influencing therapeutic efficacy in advanced SMARCA4-deficient non-small cell lung cancer. Lung cancer (Amsterdam, Netherlands) 2024 11 198 108022. Hui Liu, Qiyuan Hong, Shuohan Zheng, Meifang Zhang, Ling C |
CTLA4 blockade abrogates KEAP1/STK11-related resistance to PD-(L)1 inhibitors. Nature 2024 10 . Ferdinandos Skoulidis, Haniel A Araujo, Minh Truong Do, Yu Qian, Xin Sun, Ana Galan Cobo, John T Le, Meagan Montesion, Rachael Palmer, Nadine Jahchan, Joseph M Juan, Chengyin Min, Yi Yu, Xuewen Pan, Kathryn C Arbour, Natalie Vokes, Stephanie T Schmidt, David Molkentine, Dwight H Owen, Regan Memmott, Pradnya D Patil, Melina E Marmarelis, Mark M Awad, Joseph C Murray, Jessica A Hellyer, Justin F Gainor, Anastasios Dimou, Christine M Bestvina, Catherine A Shu, Jonathan W Riess, Collin M Blakely, Chad V Pecot, Laura Mezquita, Fabrizio Tabbó, Matthias Scheffler, Subba Digumarthy, Meghan J Mooradian, Adrian G Sacher, Sally C M Lau, Andreas N Saltos, Julia Rotow, Rocio Perez Johnson, Corinne Liu, Tyler Stewart, Sarah B Goldberg, Jonathan Killam, Zenta Walther, Kurt Schalper, Kurtis D Davies, Mark G Woodcock, Valsamo Anagnostou, Kristen A Marrone, Patrick M Forde, Biagio Ricciuti, Deepti Venkatraman, Eliezer M Van Allen, Amy L Cummings, Jonathan W Goldman, Hiram Shaish, Melanie Kier, Sharyn Katz, Charu Aggarwal, Ying Ni, Joseph T Azok, Jeremy Segal, Lauren Ritterhouse, Joel W Neal, Ludovic Lacroix, Yasir Y Elamin, Marcelo V Negrao, Xiuning Le, Vincent K Lam, Whitney E Lewis, Haley N Kemp, Brett Carter, Jack A Roth, Stephen Swisher, Richard Lee, Teng Zhou, Alissa Poteete, Yifan Kong, Tomohiro Takehara, Alvaro Guimaraes Paula, Edwin R Parra Cuentas, Carmen Behrens, Ignacio I Wistuba, Jianjun Zhang, George R Blumenschein, Carl Gay, Lauren A Byers, Don L Gibbons, Anne Tsao, J Jack Lee, Trever G Bivona, D Ross Camidge, Jhannelle E Gray, Natasha Lieghl, Benjamin Levy, Julie R Brahmer, Marina C Garassino, David R Gandara, Edward B Garon, Naiyer A Rizvi, Giorgio Vittorio Scagliotti, Jürgen Wolf, David Planchard, Benjamin Besse, Roy S Herbst, Heather A Wakelee, Nathan A Pennell, Alice T Shaw, Pasi A Jänne, David P Carbone, Matthew D Hellmann, Charles M Rudin, Lee Albacker, Helen Mann, Zhou Zhu, Zhongwu Lai, Ross Stewart, Solange Peters, Melissa L Johnson, Kwok K Wong, Alan Huang, Monte M Winslow, Michael J Rosen, Ian P Winters, Vassiliki A Papadimitrakopoulou, Tina Cascone, Philip Jewsbury, John V Heyma |
Non small cell lung cancer with SMARCA4 deficiency harboring rare EGFR mutations exhibited significant tumor response when treated with afatinib: a case report. Frontiers of medicine 2025 1 . Xiaotong Qiu, Liangkun You, Chongwei Wang, Jin She |
- Page last reviewed:Feb 1, 2024
- Content source: